|
1
|
Nicoll R and Henein M: Arterial
calcification: A new perspective? Int J Cardiol. 228:11–22.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rennenberg RJ, Kessels AG, Schurgers LJ,
van Engelshoven JM, de Leeuw PW and Kroon AA: Vascular
calcifications as a marker of increased cardiovascular risk: A
meta-analysis. Vasc Health Risk Manag. 5:185–197. 2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kuro-o M: Klotho in health and disease.
Curr Opin Nephrol Hypertens. 21:362–368. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kuro-o M: Klotho and the aging process.
Korean J Intern Med. 26:113–122. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Leopold JA: Vascular calcification:
Mechanisms of vascular smooth muscle cell calcification. Trends
Cardiovasc Med. 25:267–274. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ullah M and Sun Z: Klotho deficiency
accelerates stem cells aging by impairing telomerase activity. J
Gerontol A Biol Sci Med Sci. 74:1396–1407. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang W, Xue D, Hu D, Xie T, Tao Y, Zhu T,
Chen E and Pan Z: Secreted klotho protein attenuates osteogenic
differentiation of human bone marrow mesenchymal stem cells in
vitro via inactivation of the FGFR1/ERK signaling pathway. Growth
Factors. 33:356–365. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang L and Xu Q: Stem/Progenitor cells in
vascular regeneration. Arterioscler Thromb Vasc Biol. 34:1114–1119.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Campagnolo P, Wong MM and Xu Q: Progenitor
cells in arteriosclerosis: Good or bad guys? Antioxid Redox Signal.
15:1013–1027. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xie C, Ouyang L, Chen J, Zhang H, Luo P,
Wang J and Huang H: The emerging role of mesenchymal stem cells in
vascular calcification. Stem Cells Int.
2019(2875189)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zou S, Ren P, Zhang L, Azares AR, Zhang S,
Coselli JS, Shen YH and LeMaire SA: Activation of bone
marrow-derived cells and resident aortic cells during aortic
injury. J Surg Res. 245:1–12. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen Q, Yang M, Wu H, Zhou J, Wang W,
Zhang H, Zhao L, Zhu J, Zhou B, Xu Q and Zhang L: Genetic lineage
tracing analysis of c-kit+ stem/progenitor cells
revealed a contribution to vascular injury-induced neointimal
lesions. J Mol Cell Cardiol. 121:277–286. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Burtenshaw D, Hakimjavadi R, Redmond EM
and Cahill PA: Nox, reactive oxygen species and regulation of
vascular cell fate. Antioxidants (Basel). 14(90)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bostrom KI: Where do we stand on vascular
calcification? Vascul Pharmacol 2016:. 84:8–14. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Leszczynska A and Murphy JM: Vascular
calcification: Is it rather a stem/progenitor cells driven
phenomenon? Front Bioeng Biotechnol. 6(10)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dzhoyashvili NA, Efimenko AY, Kochegura
TN, Kalinina NI, Koptelova NV, Sukhareva OY, Shestakova MV,
Akchurin RS, Tkachuk VA and Parfyonova YV: Disturbed angiogenic
activity of adipose-derived stromal cells obtained from patients
with coronary artery disease and diabetes mellitus type 2. J Transl
Med. 12(337)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ikeda Y, Kumagai H, Motozawa Y, Suzuki J,
Akazawa H and Komuro I: Understanding vascular diseases: Lessons
from premature aging syndromes. Can J Cardiol. 32:650–658.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Khodayari S, Khodayari H, Amiri AZ, Eslami
M, Farhud D, Hescheler J and Nayernia K: Inflammatory
microenvironment of acute myocardial infarction prevents
regeneration of heart with stem cells therapy. Cell Physiol
Biochem. 53:887–909. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fadini GP, Albiero M, Menegazzo L, Boscaro
E, Agostini C, de Kreutzenberg SV, Rattazzi M and Avogaro A:
Procalcific phenotypic drift of circulating progenitor cells in
type 2 diabetes with coronary artery disease. Exp Diabetes Res.
2012(921685)2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cianciolo G, Capelli I, Cappuccilli M,
Scrivo A, Donadei C, Marchetti A, Rucci P and La Manna G: Is
chronic kidney disease-mineral and bone disorder associated with
the presence of endothelial progenitor cells with a calcifying
phenotype? Clin Kidney J. 10:389–396. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kramann R, Goettsch C, Wongboonsin J,
Iwata H, Schneider RK, Kuppe C, Kaesler N, Chang-Panesso M, Machado
FG, Gratwohl S, et al: Adventitial MSC-like cells are progenitors
of vascular smooth muscle cells and drive vascular calcification in
chronic kidney disease. Cell Stem Cell. 19:628–642. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kramann R, Kunter U, Brandenburg VM,
Leisten I, Ehling J, Klinkhammer BM, Knüchel R, Floege J and
Schneider RK: Osteogenesis of heterotopically transplanted
mesenchymal stromal cells in rat models of chronic kidney disease.
J Bone Miner Res. 28:2523–2534. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zununi Vahed S, Mostafavi S, Hosseiniyan
Khatibi SM, Shoja MM and Ardalan M: Vascular calcification: An
important understanding in nephrology. Vasc Health Risk Manag.
16:167–180. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Guerrero F, Herencia C, Almaden Y,
Martinez-Moreno JM, Montes de Oca A, Rodriguez-Ortiz ME,
Diaz-Tocados JM, Canalejo A, Florio M, López I, et al: TGF-β
prevents phosphate-induced osteogenesis through inhibition of BMP
and Wnt/β-catenin pathways. PLoS One. 9(e89179)2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Evrard S, Delanaye P, Kamel S, Cristol JP
and Cavalier E: SFBC/SN joined working group on vascular
calcifications. Vascular calcification: From pathophysiology to
biomarkers. Clin Chim Acta. 438:401–414. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang CL, Xiao F, Wang CD, Zhu JF, Shen C,
Zuo B, Wang H, Li D, Wang XY, Feng WJ, et al: Gremlin2 suppression
increases the BMP-2-induced osteogenesis of human bone
marrow-derived mesenchymal stem cells via the BMP-2/Smad/Runx2
signaling pathway. J Cell Biochem. 118:286–297. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen Y, Zhao X and Wu H: Arterial
stiffness: A focus on vascular calcification and its link to bone
mineralization. Arterioscler Thromb Vasc Biol. 40:1078–1093.
2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Byon CH, Javed A, Dai Q, Kappes JC,
Clemens TL, Darley-Usmar VM, McDonald JM and Chen Y: Oxidative
stress induces vascular calcification through modulation of the
osteogenic transcription factor Runx2 by AKT signaling. J Biol
Chem. 283:15319–15327. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sim HJ, Kim JH, Kook SH, Lee SY and Lee
JC: Glucose oxidase facilitates osteogenic differentiation and
mineralization of embryonic stem cells through the activation of
Nrf2 and ERK signal transduction pathways. Mol Cell Biochem.
419:157–163. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sprague AH and Khalil RA: Inflammatory
cytokines in vascular dysfunction and vascular disease. Biochem
Pharmacol. 78:539–552. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shobeiri N and Bendeck MP: Interleukin-1β
Is a key biomarker and mediator of inflammatory vascular
calcification. Arterioscler Thromb Vasc Biol. 37:179–180.
2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Han L, Zhang Y, Zhang M, Guo L, Wang J,
Zeng F, Xu D, Yin Z, Xu Y, Wang D and Zhou H:
Interleukin-1β-induced senescence promotes osteoblastic transition
of vascular smooth muscle cells. Kidney Blood Press Res.
45:314–330. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ciavarella C, Gallitto E, Ricci F, Buzzi
M, Stella A and Pasquinelli G: The crosstalk between vascular MSCs
and inflammatory mediators determines the pro-calcific remodelling
of human atherosclerotic aneurysm. Stem Cell Res Ther.
8(99)2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hegner B, Schaub T, Janke D, Zickler D,
Lange C, Girndt M, Jankowski J, Schindler R and Dragun D: Targeting
proinflammatory cytokines ameliorates calcifying phenotype
conversion of vascular progenitors under uremic conditions in
vitro. Sci Rep. 8(12087)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Voelkl J, Alesutan I, Leibrock CB,
Quintanilla-Martinez L, Kuhn V, Feger M, Mia S, Ahmed MS,
Rosenblatt KP, Kuro-O M and Lang F: Spironolactone ameliorates
PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice.
J Clin Invest. 123:812–822. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Chen J, Lin Y and Sun Z: Deficiency in the
anti-aging gene Klotho promotes aortic valve fibrosis through
AMPKalpha-mediated activation of RUNX2. Aging Cell. 15:853–860.
2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sun H, Zhang F, Xu Y, Sun S, Wang H, Du Q,
Gu C, Black SM, Han Y and Tang H: Salusin-β promotes vascular
calcification via nicotinamide adenine dinucleotide
phosphate/reactive oxygen species-mediated klotho downregulation.
Antioxid Redox Signal. 31:1352–1370. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fan J and Sun Z: The antiaging gene klotho
regulates proliferation and differentiation of adipose-derived stem
cells. Stem Cells. 34:1615–1625. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Vadakke Madathil S, Coe LM, Casu C and
Sitara D: Klotho deficiency disrupts hematopoietic stem cell
development and erythropoiesis. Am J Pathol. 184:827–841.
2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Bian A, Neyra JA, Zhan M and Hu MC:
Klotho, stem cells, and aging. Clin Interv Aging. 10:1233–1243.
2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Bartoli-Leonard F, Wilkinson FL,
Langford-Smith AWW, Alexander MY and Weston R: The interplay of
SIRT1 and Wnt signaling in vascular calcification. Front Cardiovasc
Med. 5(183)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Cai T, Sun D, Duan Y, Wen P, Dai C, Yang J
and He W: WNT/β-catenin signaling promotes VSMCs to osteogenic
transdifferentiation and calcification through directly modulating
Runx2 gene expression. Exp Cell Res. 345:206–217. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Wang W, Li C, Pang L, Shi C, Guo F, Chen
A, Cao X and Wan M: Mesenchymal stem cells recruited by active TGFβ
contribute to osteogenic vascular calcification. Stem Cells Dev.
23:1392–1404. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chen YX, Huang C, Duan ZB, Xu CY and Chen
Y: Klotho/FGF23 axis mediates high phosphate-induced vascular
calcification in vascular smooth muscle cells via Wnt7b/β-catenin
pathway. Kaohsiung J Med Sci. 35:393–400. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi
H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, et
al: Mutation of the mouse klotho gene leads to a syndrome
resembling ageing. Nature. 390:45–51. 1997.PubMed/NCBI View
Article : Google Scholar
|
|
46
|
Hum JM, O'Bryan LM, Tatiparthi AK, Cass
TA, Clinkenbeard EL, Cramer MS, Bhaskaran M, Johnson RL, Wilson JM,
Smith RC and White KE: Chronic hyperphosphatemia and vascular
calcification are reduced by stable delivery of soluble klotho. J
Am Soc Nephrol. 28:1162–1174. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chen T, Mao H, Chen C, Wu L, Wang N, Zhao
X, Qian J and Xing C: The role and mechanism of α-Klotho in the
calcification of rat aortic vascular smooth muscle cells. Biomed
Res Int. 2015(194362)2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Liu L, Liu Y, Zhang Y, Bi X, Nie L, Liu C,
Xiong J, He T, Xu X, Yu Y, et al: High phosphate-induced
downregulation of PPARγ contributes to CKD-associated vascular
calcification. J Mol Cell Cardiol. 114:264–275. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chang JR, Guo J, Wang Y, Hou YL, Lu WW,
Zhang JS, Yu YR, Xu MJ, Liu XY, Wang XJ, et al: Intermedin1-53
attenuates vascular calcification in rats with chronic kidney
disease by upregulation of α-Klotho. Kidney Int. 89:586–600.
2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Hu MC, Shi M, Zhang J, Quinones H,
Griffith C, Kuro-o M and Moe OW: Klotho deficiency causes vascular
calcification in chronic kidney disease. J Am Soc Nephrol.
22:124–136. 2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Golembiewska E, Stepniewska J,
Kabat-Koperska J, Kedzierska K, Domanski M and Ciechanowski K: The
role of klotho protein in chronic kidney disease: Studies in
animals and humans. Curr Protein Pept Sci. 17:821–826.
2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Kuro OM: The Klotho proteins in health and
disease. Nat Rev Nephrol. 15:27–44. 2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Olejnik A, Franczak A, Krzywonos-Zawadzka
A, Kaluzna-Oleksy M and Bil-Lula I: The biological role of klotho
protein in the development of cardiovascular diseases. Biomed Res
Int. 2018(5171945)2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Henaut L, Chillon JM, Kamel S and Massy
ZA: Updates on the mechanisms and the care of cardiovascular
calcification in chronic kidney disease. Semin Nephrol. 38:233–250.
2018.PubMed/NCBI View Article : Google Scholar
|
